SINTILIMAB

Search structure
Synonyms:
Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 8FU7FQ8UPK

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Programmed cell death protein 1 antagonist

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Carcinoma, Hepatocellular 3 D006528 ClinicalTrials
Colorectal Neoplasms 3 D015179 ClinicalTrials
Lung Neoplasms 3 D008175 ClinicalTrials
Hodgkin Disease 3 D006689 ClinicalTrials
Breast Neoplasms 3 D001943 ClinicalTrials
Colorectal Neoplasms 3 D015179 ClinicalTrials
Hodgkin Disease 3 D006689 ClinicalTrials
Stomach Neoplasms 3 D013274 ClinicalTrials
Lung Neoplasms 3 D008175 ClinicalTrials
Stomach Neoplasms 3 D013274 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 3 D002289 ClinicalTrials
Nasopharyngeal Neoplasms 3 D009303 ClinicalTrials
Colorectal Neoplasms 3 D015179 ClinicalTrials
Stomach Neoplasms 3 D013274 ClinicalTrials
Stomach Neoplasms 3 D013274 ClinicalTrials
Esophageal Neoplasms 3 D004938 ClinicalTrials
Esophageal Neoplasms 3 D004938 ClinicalTrials
Colorectal Neoplasms 3 D015179 ClinicalTrials
Esophageal Neoplasms 3 D004938 ClinicalTrials
Cholangiocarcinoma 2 D018281 ClinicalTrials
Sarcoma 2 D012509 ClinicalTrials
Uterine Cervical Neoplasms 2 D002583 ClinicalTrials
Carcinoma, Squamous Cell 2 D002294 ClinicalTrials
Immunoblastic Lymphadenopathy 2 D007119 ClinicalTrials
Carcinoma, Renal Cell 2 D002292 ClinicalTrials
Endometrial Neoplasms 2 D016889 ClinicalTrials
Squamous Cell Carcinoma of Head and Neck 2 D000077195 ClinicalTrials
Mesothelioma 2 D008654 ClinicalTrials
Pancreatic Neoplasms 2 D010190 ClinicalTrials
Pancreatic Neoplasms 2 D010190 ClinicalTrials
Hemangiosarcoma 2 D006394 ClinicalTrials
Cholangiocarcinoma 2 D018281 ClinicalTrials
Neuroendocrine Tumors 2 D018358 ClinicalTrials
Histiocytoma, Malignant Fibrous 2 D051677 ClinicalTrials
Carcinoma, Neuroendocrine 2 D018278 ClinicalTrials
Salivary Gland Neoplasms 2 D012468 ClinicalTrials
Glioblastoma 2 D005909 ClinicalTrials
Pancreatic Neoplasms 2 D010190 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
Gallbladder Neoplasms 2 D005706 ClinicalTrials
Carcinoma, Squamous Cell 2 D002294 ClinicalTrials
Uterine Cervical Neoplasms 2 D002583 ClinicalTrials
Salivary Gland Neoplasms 2 D012468 ClinicalTrials
Adenocarcinoma 2 D000230 ClinicalTrials
Nasopharyngeal Carcinoma 2 D000077274 ClinicalTrials
Lymphoma 2 D008223 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
Small Cell Lung Carcinoma 2 D055752 ClinicalTrials
Lymphoma, Large B-Cell, Diffuse 2 D016403 ClinicalTrials
Carcinoma, Renal Cell 2 D002292 ClinicalTrials
Sarcoma 2 D012509 ClinicalTrials
Carcinoma, Squamous Cell 2 D002294 ClinicalTrials
Uterine Cervical Neoplasms 2 D002583 ClinicalTrials
Lymphoma, T-Cell, Cutaneous 2 D016410 ClinicalTrials
Mouth Neoplasms 2 D009062 ClinicalTrials
Biliary Tract Neoplasms 2 D001661 ClinicalTrials
Ovarian Neoplasms 2 D010051 ClinicalTrials
Granuloma, Lethal Midline 2 D006103 ClinicalTrials
Squamous Cell Carcinoma of Head and Neck 2 D000077195 ClinicalTrials
Lymphoma, T-Cell, Peripheral 2 D016411 ClinicalTrials
Adenocarcinoma, Clear Cell 2 D018262 ClinicalTrials
Neuroblastoma 2 D009447 ClinicalTrials
Rectal Neoplasms 2 D012004 ClinicalTrials
Carcinoma 1 D002277 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297829
FDA SRS 8FU7FQ8UPK
CONTENTS